(Q36565053)

15 August 2017

1 reference

title

Hypersensitivity reactions associated with oxaliplatin (English)

1 reference

15 August 2017

1 reference

M Wasif Saif

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Expert Opinion on Drug Safety

15 August 2017

published in

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

687-694

1 reference

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity Reactions to Chemotherapeutic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity and idiosyncratic reactions to oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reactions related to oxaliplatin (OHP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Oxaliplatin-induced fever and release of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Reaction after oxaliplatin--prevention with corticosteroids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Idiosyncratic reaction after oxaliplatin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Skin testing and hypersensitivity reactions to oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Successful desensitization to oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

Anaphylaxis to cisplatin following nine previous uncomplicated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.5.687

21 January 2018

Identifiers

DOI

10.1517/14740338.5.5.687

1 reference

15 August 2017

1 reference